IP Group

IP Group

IP Group is a company that develops intellectual property-based businesses, is headquartered in London, United Kingdom and was founded in 2001.

IP Group is a leading intellectual property commercialisation company which focuses on evolving ideas from its partner universities and turn these into businesses. They are helping to create, build, and support early-stage to mature businesses across Life Sciences, Cleantech and Technology. IP Group is supporting their portfolio companies with financial capital, strategic and commercial expertise, executive search and development, corporate finance and and capital raising, and a range of administrative services. The Group began their long-term partnership model with United Kingdom universities and replicated this approach in research institutions in United States and in 2017, they expanded into Australasia.

Investments

IP Group has raised a total of $227.4M across 3 funds. IP Group, also known as IPO in the Main Market, is a constituent of the FTSE 250 Index and being traded in the London Stock Exchange.

Timeline

Funded Companies

Company
Description
Industry
Website
Location
Oxford Nanopore Technologies

DNA sequencing company specializing in rapid long-read sequencing through nanopores.

Nanotechnology
Oxford
WaveOptics

A technology company designing and manufacturing diffractive waveguides for augmented reality devices.

Manufacturing
England
Ultrahaptics

A technology company making mid-air haptics for creating three-dimensional shapes and textures that can be felt.

Import.io

Import.io is a Los Gatos, California-based company founded in 2012 by David White.

Artificial intelligence (AI)
San Francisco
Exyn

A startup developing autonomous aerial robots.

Robotics
Philadelphia
Inivata

A clinical cancer genomics company using liquid biopsy in cancer patients

Biotechnology
London
Artios Pharma

Artios Pharma develops cancer treatments that target DNA Damage Response (DDR) Pathways to selectively kill cancer cells

Cancer
Cambridge, Cambridgeshire
Blooie

Company

Surrey Nanosystems

Company

Nanotechnology
Alesi Surgical Limited

Carisma Therapeutics

Carisma Therapeutics is a Philadelphia County, Pennsylvania-based company.

Philadelphia County, Pennsylvania
Magnomatics

Seren Photonics

TheySay

TheySay is a London-based artificial intelligence company.

Artificial intelligence (AI)
London
Glythera

Ubiquigent

Deltasight

Structure Vision

Durham Graphene Science

Xanic

Oxtox

Crysalin

Activiomics

23 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Alan Aubrey

Chief Executive Officer

David Baynes

Chief Operating Officer

Dr Elaine Sullivan

Non-executive Director

Greg Smith

Chief Financial Officer

Heejae Chae

Non-executive Director

Jonathan Brooks

Non-executive Director

Mike Townend

Chief Investment Officer

Prof David Begg

Senior Independent Director

Sir Douglas Flint, CBE

Non-executive Chairman

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Actual Experience plc

Dave Page

London

Cloud-based analytics

Autifony Therapeutics Ltd

Charles H. Large, PhD

United Kingdom

Developing high value, novel medicines to treat serious diseases of the central nervous system

Cell Medica Ltd

Chris Nowers

United Kingdom

Cellular immunotherapy products for the treatment of cancer and infections

Ceres Power Holdings plc

Phil Caldwell

United Kingdom

Ceramic fuel cell technology for distributed generation

Circassia Pharmaceuticals plc

Steve Harris

United Kingdom

Specialty pharmaceutical company focused on respiratory disease

Diurnal Group plc

United Kingdom

A global pharmaceutical company focused on chronic endocrine conditions

Istesso Ltd

Design and development of novel therapeutic drugs

Oxford Nanopore Technologies Ltd

Dr Gordon Sanghera

United Kingdom

Electronics-based DNA/RNA sequencing technology

Oxford Sciences Innovation plc

United Kingdom

Commercialization of intellectual property from the University of Oxford

PsiOxus Therapeutics Ltd

Dr John Beadle

United Kingdom

Systemic delivery of tumour-targeted oncolytic immune therapeutics

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.